Interventional Cardiology Devices Market Size – USD 13.72 Billion in 2020, Market Growth – at a CAGR of 8.7%, Market Trends – Technological Advancements
— Emerging research
VANCOUER, BC, CANADA, June 20, 2022 /EINPresswire.com/ — The Global interventional cardiology devices market the size is expected to reach USD 26.84 billion at a stable CAGR of 8.7% in 2028, according to the latest analysis from Emergen Research. The steady growth of the interventional cardiology devices market can be attributed to the increasing incidence of cardiovascular diseases. Cardiovascular disease is the most common cause of death in the United States and is responsible for approximately 655,000 deaths each year. Coronary artery disease is the leading type of heart disease that in 2017 killed 365,914 people in the United States.
Key players in the Interventional Cardiology Devices market are Abbott Laboratories, Terumo Corporation, iVascular, Boston Scientific Corporation, Edwards Lifesciences Corporation, B.Braun Melsungen, Medtronic PLC, Koninklijke Philips NV, Biosensors International Group Ltd. and Endocor GmbH.
𝐆𝐞𝐭 𝐟𝐫𝐞𝐞 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐂𝐚𝐫𝐝𝐢𝐨𝐥𝐨𝐠𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝟐𝟎𝟐𝟐 𝟐𝟎𝟐𝟐: https://www.emergenresearch.com/request-sample/570
The research report on Global Interventional Cardiology Devices Market is formulated with insightful data that will help both established companies and new entrants to analyze business trends and capitalize on investment strategies. The Interventional Cardiology Devices market is analyzed with the aim of helping readers gain maximum return on investment and enable informed decision-making process.
Emergen Research follows a consistent methodology to reduce residual errors to a minimum level by refining the scope, validating with primary information and regularly feeding the internal database. A dynamic model is formulated to capture regular fluctuations in the market and hence be updated with any changes in market dynamics. The parameters and variables involved in the research vary with individual markets and, more importantly, demand and supply information is included in the model to identify the market gap.
𝐊𝐞𝐲 𝐢𝐧𝐜𝐥𝐮𝐬𝐢𝐨𝐧𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐈𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐚𝐫𝐝𝐢𝐨𝐥𝐨𝐠𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐫𝐞𝐩𝐨𝐫𝐭:
Effects of COVID-19 on growth figures.
Statistical analysis related to market size, sales volume and overall industry revenue.
Organized mentions of key market trends.
Opportunities for growth.
Figures showing market growth rate.
Advantages and disadvantages of direct and indirect sales channels.
Overviews regarding traders, distributors and resellers present in the industry.
In June 2019, Terumo Corporation signed a partnership agreement with Orchestra BioMed, Inc. This partnership grants Terumo Corporation the exclusive rights for the development and commercialization of Virtue Sirolimus-Eluting Balloon (SEB).
Angioplasty stents find application in restoring blood flow resulting from a blockage and in reducing the risk of heart attack. Stents are considered beneficial in reducing damage to heart muscles in the event of a heart attack. Additionally, stents can instantly relieve or reduce symptoms such as chest pain, fatigue, and shortness of breath.
Among the end-use segments, the hospital segment accounted for the largest revenue share in 2020, which can be attributed to the strong presence of experienced healthcare professionals for the installation of interventional cardiology devices and more advanced and developed healthcare infrastructure, as well as high purchasing power for advanced devices. and dedicated interventional cardiology devices in the countries of the region. Additionally, hospitals consider minimizing adverse events in patients during critical procedures, including stent placement and cardiac catheterization.
Access full report description, table of contents, table of figure, graph, etc. @ https://www.emergenresearch.com/industry-report/interventional-cardiology-devices-market
The research study on the Interventional Cardiology Devices market historical, current and forecast estimates for each industry, segment, sub-segment and regions. The new report is updated with the impact of the COVID-19 pandemic on the Interventional Cardiology Devices market.
𝐄𝐦𝐞𝐫𝐠𝐞𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐡𝐚𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐢𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧𝐚𝐥 𝐜𝐚𝐫𝐝𝐢𝐨𝐥𝐨𝐠𝐲 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐭𝐡𝐞 𝐛𝐚𝐬𝐢𝐬 𝐨𝐟 𝐩𝐫𝐨𝐝𝐮𝐜𝐭 𝐭𝐲𝐩𝐞, 𝐞𝐧𝐝-𝐮𝐬𝐞, 𝐚𝐧𝐝 𝐫𝐞𝐠𝐢𝐨𝐧:
𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞, 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧; 𝟐𝟎𝟏𝟖 – 𝟐𝟎𝟐𝟖)
Structural heart devices
Plate modification devices
Hemodynamic Flow Modification Devices
𝐄𝐧𝐝 -𝐔𝐬𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞, 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧; 𝟐𝟎𝟏𝟖 – 𝟐𝟎𝟐𝟖)
Ambulatory surgery centers
Geographically, this report studies key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:
South East Asia
𝐖𝐞 𝐜𝐚𝐧 𝐚𝐥𝐬𝐨 𝐩𝐫𝐨𝐯𝐢𝐝𝐞 𝐭𝐡𝐞 𝐬𝐞𝐩𝐚𝐫𝐚𝐭𝐞 𝐫𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐨𝐫 𝐜𝐨𝐮𝐧𝐭𝐫𝐲 𝐜𝐨𝐮𝐧𝐭𝐫𝐲 𝐫𝐞𝐩𝐨𝐫𝐭𝐬 𝐫𝐞𝐩𝐨𝐫𝐭𝐬, 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐟𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠:
North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, United Kingdom, Italy, Spain, Russia, Rest of Europe, Central and South America, Brazil, Argentina, Rest of South America, Middle East and Africa, Saudi Arabia, Turkey, Rest of Middle East and Africa
𝐓𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐬𝐡𝐚𝐫𝐞𝐬 :
Current market size
Main Drivers and Constraints
New product approvals/launch
Promotion and marketing initiatives
𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐤𝐞𝐲 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐬𝐰𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭:
What is the size of the global Interventional Cardiology Devices market and its segments?
What are the key segments and sub-segments of the market?
What are the key drivers, restraints, opportunities and challenges in the Interventional Cardiology Devices market and what is their impact on the market?
What are the attractive investment opportunities in the Interventional Cardiology Devices market?
What is the size of the Interventional Cardiology Devices market at the regional and country level?
Who are the main market players and their main competitors?
What are the growth strategies adopted by the key players of the Interventional Cardiology Devices market?
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting firm with an extensive knowledge base on cutting-edge and potentially market-disrupting technologies that are expected to become more prevalent over the next decade.
Thank you for reading our report. For more details or to inquire about customization, please let us know. We will offer you the report according to your requirement.
Global Interventional Cardiology Devices Market Size Expected to Reach USD 26.84 Billion at a Steady CAGR of 8.7% in 2028 by Emergen Research